icon-    folder.gif   Conference Reports for NATAP  
  Conference on Retroviruses
and Opportunistic Infections (CROI)
February 22-25, 2016, Boston MA
Back grey_arrow_rt.gif
2 Dapivirine Vaginal Ring Studies
  CROI:A Phase III Trial of the Dapivirine Vaginal Ring for HIV-1 Prevention in Women - (02/29/16)....37% protection.....61% if > 25 years old
CROI:Safety and Efficacy of Dapvirine Vaginal Ring for HIV-1 Prevention in African Women....31% reduction in HIV-infection....15% if <21 years old & 37% if >21 years old....analysis for better adherence found 65% protection